About

Dr. Achille Aveta is a pioneering urologic surgeon whose research centers on advancing robotic-assisted surgery for urologic cancers, with a particular focus on renal cell carcinoma, prostate cancer, and penile cancer. His most impactful work includes a comprehensive systematic review on robotic-assisted partial nephrectomy (RAPN) for renal hilar masses, which has garnered 48 citations and established best practices for this complex procedure. Dr. Aveta has also made significant contributions to prostate cancer care, demonstrating through 47-cited research how biomarkers like 8-OHdG and 8-iso-prostaglandin F2α can assess oxidative stress damage following robot-assisted radical prostatectomy (RARP). His expertise extends to innovative applications of the da Vinci SP® single-port system, where he reported the first Italian experience with supine anterior retroperitoneal access for partial nephrectomy. Dr. Aveta’s work on Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients has refined preoperative assessment protocols, while his studies on postoperative pain management and varicocele surgery showcase his commitment to improving patient outcomes across the surgical spectrum. With over 150 cumulative citations, Dr. Aveta continues to shape the future of minimally invasive urologic oncology.

Research Focus

Key Achievements

6
H-Index
10
Papers
157
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic Review
48 citations · 2024
📈 Most Prolific Year: 2025 (4 Papers)
🤝 Key Collaborators: 77
🏛 Institutions: University of Naples Federico II, Ceinge Biotecnologie Avanzate (Italy), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago